These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6540682)

  • 21. Diagnosis and management of perianal and perirectal infection in the granulocytopenic patient.
    Rolston KV; Bodey GP
    Curr Clin Top Infect Dis; 1993; 13():164-71. PubMed ID: 8397908
    [No Abstract]   [Full Text] [Related]  

  • 22. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients.
    De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC
    Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
    Baruchel A; Hartmann O; Andremont A; Tancrède C
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review of amikacin usage in the EORTC trials.
    Zinner SH
    Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gram-positive infections in granulocytopenic patients: an important issue?
    Viscoli C; Van der Auwera P; Meunier F
    J Antimicrob Chemother; 1988 Apr; 21 Suppl C():149-56. PubMed ID: 3290182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a combination of cefotaxime, tobramycin and vancomycin as antibiotic therapy for neutropenia.
    Brunet F; Lanore JJ; Dhainaut JF; Dreyfus F; Huyghebaert MF; Varet B; Monsallier JF
    Drugs; 1988; 35 Suppl 2():195. PubMed ID: 3396480
    [No Abstract]   [Full Text] [Related]  

  • 27. [Criteria for the estimation of clinical effect of antimicrobial drugs in the treatment of infections associated with granulocytopenia].
    Takaku F; Nagai K; Maekawa T; Masaoka T
    Rinsho Ketsueki; 1984 Apr; 25(4):588-92. PubMed ID: 6471442
    [No Abstract]   [Full Text] [Related]  

  • 28. [Infections in granulocytopenic patients].
    Erard P
    Rev Med Suisse Romande; 1981 Feb; 101(2):89-98. PubMed ID: 6262897
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention using pefloxacin of infections in cancer patients with granulocytopenia].
    Leleux A; Snoeck R; Gerain J; Van der Auwera P; Daneau D; Meunier F
    Presse Med; 1989 Jan 7-14; 18(1):21-4. PubMed ID: 2521710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. After empiric therapy: what to do until the granulocyte comes back.
    Pizzo PA
    Rev Infect Dis; 1987; 9(1):214-9. PubMed ID: 3547574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients.
    Meunier F; Snoeck R; Lagast H; Woussen F; Klastersky J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():195-201. PubMed ID: 3636334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of infections in granulocytopenic and immunocompromised cancer patients.
    Klastersky J
    Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():25-34. PubMed ID: 3138351
    [No Abstract]   [Full Text] [Related]  

  • 33. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
    Klastersky J
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empiric therapy of febrile granulocytopenic patients.
    Hopefl AW
    Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective randomly controlled trial of three antibiotic combinations for empirical therapy of suspected sepsis in neutropenic cancer patients.
    Gaya H; Klastersky J; Schimpff SC; Fière D; Widmaier S; Nagel G
    Eur J Cancer (1965); 1975 Aug; 11suppl():5-8. PubMed ID: 767119
    [No Abstract]   [Full Text] [Related]  

  • 36. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
    Rolston KV; Bodey GP; Elting L
    Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials.
    Klastersky J; Zinner SH; Calandra T; Gaya H; Glauser MP; Meunier F; Rossi M; Schimpff SC; Tattersall M; Viscoli C
    Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S35-45. PubMed ID: 3280326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of infection in myelosuppressed patients: clinical trials and common sense.
    Greene WH
    Exp Hematol; 1985; 13 Suppl 16():80-8. PubMed ID: 3987839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combating infections in neutropenic patients.
    Pizzo PA
    Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin.
    De Jongh CA; Wade JC; Schimpff SC; Newman KA; Finley RS; Salvatore PC; Moody MR; Standiford HC; Fortner CL; Wiernik PH
    Am J Med; 1982 Jul; 73(1):89-96. PubMed ID: 6211981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.